Upping the Dose Of Enforcement: FTC To Re-Evaluate Its Pharmaceutical Merger Analysis
By EsqSocial Corporation 25/03/21
On March 16, 2021, the Federal Trade Commission (“FTC”) announced its plans to initiate an international working group that will “identify concrete and actionable steps to review and update the analysis of pharmaceutical mergers.”1 According to FTC Acting Chair Rebecca Kelly Slaughter, the initiative will incorporate expertise from a number of competition authorities to help address the competitive concerns created by these mergers......
By: Vinson & Elkins LLP